LLY

947.62

-2.8%↓

JNJ

221.12

-0.62%↓

ABBV

201.14

-0.71%↓

UNH

379.44

+2.66%↑

AZN

182.32

+0.05%↑

LLY

947.62

-2.8%↓

JNJ

221.12

-0.62%↓

ABBV

201.14

-0.71%↓

UNH

379.44

+2.66%↑

AZN

182.32

+0.05%↑

LLY

947.62

-2.8%↓

JNJ

221.12

-0.62%↓

ABBV

201.14

-0.71%↓

UNH

379.44

+2.66%↑

AZN

182.32

+0.05%↑

LLY

947.62

-2.8%↓

JNJ

221.12

-0.62%↓

ABBV

201.14

-0.71%↓

UNH

379.44

+2.66%↑

AZN

182.32

+0.05%↑

LLY

947.62

-2.8%↓

JNJ

221.12

-0.62%↓

ABBV

201.14

-0.71%↓

UNH

379.44

+2.66%↑

AZN

182.32

+0.05%↑

Accueil・Liste d'Actions・NeoGenomics Inc

NeoGenomics Inc

Fermé

8.96 -1.1

Acheter Vendre

Résumé

Variation du prix de l'action

24h

Actuel

Min

8.8

Max

8.97

Chiffres clés
By Trading Economics
Revenu	-7.2M -17M
Ventes	-3.5M 187M
BPA	0.01
Marge bénéficiaire	-9.164
Employés	2,500
EBITDA	-5.8M -567K

Recommandations
By TipRanks
Recommandations	Achat
Prévisions sur 12 Mois	+66.74% upside

Dividendes
By Dow Jones
Prochains Résultats	28 juil. 2026

Statistiques du Marché
By TradingEconomics
Capitalisation Boursière	51M 1.2B
Ouverture précédente	10.06
Clôture précédente	8.96

Score Technique

By Trading Central

Confiance

Very Strong Bearish Evidence

7.7 / 10.27 Support & Résistance

NeoGenomics Inc Graphique

Les performances passées ne sont pas un indicateur fiable des résultats futurs.

Actualités Associées

7 mai 2026, 21:03 UTC

Résultats

Coinbase Global Swings to Loss Amid Softer Crypto Market

6 mai 2026, 18:06 UTC

Principaux Mouvements du Marché

Core Scientific Shares Rise on AI Data Center Expansion Plan

8 mai 2026, 17:04 UTC

Market Talk

Zcash Caps Off Parabolic Week -- Market Talk

8 mai 2026, 16:20 UTC

Market Talk

Tech, Media & Telecom Roundup: Market Talk

8 mai 2026, 15:20 UTC

Market Talk

'Altcoin Season' Indicator on the Rise -- Market Talk

8 mai 2026, 15:05 UTC

Market Talk

Bitcoin Slips Back Below the $80k Mark -- Market Talk

8 mai 2026, 12:19 UTC

Résultats

Bitcoin Price Dives Below $80,000. This Jobs Report Could End the Crypto Slump. -- Barrons.com

8 mai 2026, 10:55 UTC

Market Talk

Bitcoin Edges Higher as Risk Sentiment Improves Slightly -- Market Talk

8 mai 2026, 08:41 UTC

Résultats

Coinbase Misses Earnings and Revenue Estimates. The Stock Is Falling. -- Barrons.com

8 mai 2026, 06:25 UTC

Market Talk

Bitcoin Falls as U.S. and Iran Trade Attacks -- Market Talk

7 mai 2026, 21:25 UTC

Résultats

IREN 4Q Rev $144.80M >IREN

7 mai 2026, 20:22 UTC

Résultats

Coinbase Misses on Earnings and Revenue. The Stock Is Falling. -- Barrons.com

7 mai 2026, 14:30 UTC

Market Talk

Tokenized Assets Saw 22% Market Cap Jump in April -- Market Talk

7 mai 2026, 14:25 UTC

Market Talk

Stablecoin Market Cap Finds New High in April -- Market Talk

7 mai 2026, 11:43 UTC

Market Talk

Bitcoin's Rally Pauses as Investors Remain Cautious Over Iran War -- Market Talk

7 mai 2026, 07:00 UTC

Market Talk

Market Talk Roundup: Latest on U.S. Politics

7 mai 2026, 07:00 UTC

Market Talk

Bitcoin Eases Slightly After Rally on Iran-U.S. Peace Deal Hopes -- Market Talk

7 mai 2026, 06:00 UTC

Résultats

Coinbase Heads Into Earnings Facing a Crypto Trading Slowdown -- Barrons.com

6 mai 2026, 20:50 UTC

Market Talk

Financial Services Roundup: Market Talk

6 mai 2026, 20:50 UTC

Market Talk

Basic Materials Roundup: Market Talk

6 mai 2026, 18:46 UTC

Résultats

Acquisitions, Fusions, Rachats

Strategy Posts $14.5 Billion Loss on Bitcoin Holdings. The 'Never Sell' Mantra Fades. -- Barrons.com

6 mai 2026, 17:10 UTC

Market Talk

Coinbase Perpetual Gold and Silver Futures Go Live -- Market Talk

6 mai 2026, 16:35 UTC

Market Talk

Major Crypto Assets Show Volatility as War-Ending Deal Mulled -- Market Talk

6 mai 2026, 16:20 UTC

Market Talk

Financial Services Roundup: Market Talk

6 mai 2026, 15:12 UTC

Market Talk

Strong Gains in Privacy Coins May Signal Developing Altcoin Demand -- Market Talk

6 mai 2026, 14:55 UTC

Market Talk

CME Launching Bitcoin Volatility Futures -- Market Talk

6 mai 2026, 14:11 UTC

Résultats

Acquisitions, Fusions, Rachats

Strategy Posts $14.5 Billion Loss on Bitcoin Holdings. The 'Never Sell' Mantra Fades. -- Barrons.com

6 mai 2026, 13:59 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

6 mai 2026, 13:59 UTC

Market Talk

Cryptocurrency Breaks Out as Optimism Over War Grows -- Market Talk

6 mai 2026, 11:05 UTC

Résultats

Strategy Posts Wider Loss as Bitcoin Holdings Hit $64 Billion. The Stock Rises Anyway. -- Barrons.com

Comparaison

Variation de prix

NeoGenomics Inc prévision

Objectif de Prix

By TipRanks

66.74% hausse

Prévisions sur 12 Mois

Moyen 14.94 USD 66.74%

Haut 25 USD

Bas 11 USD

Basé sur 12 analystes de Wall Street proposant des objectifs de prix à 12 mois pour Microsoft Corp. au cours des 3 derniers mois.

Note du Consensus

By TipRanks

Achat

12 ratings

Achat

Maintien

Vente

Basé sur 12 qui ont noté l'action Microsoft Corp. au cours des 3 derniers mois.

Score Technique

By Trading Central

7.7 / 10.27Support & Résistance

Recent bearish events outweigh bullish events.

All events are bearish.

Éléments financiers

Frais Généraux et Administratifs

Dépenses d'exploitation

Résultat avant impôt

Ventes

Coût des ventes

Marge brute des ventes

Charges d'intérêt sur la dette

EBITDA

Bénéfice d'exploitation

À Propos NeoGenomics Inc

NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States and the United Kingdom. It operates through Clinical Services and Advanced Diagnostics segments. The company offers testing services to hospitals, academic centers, pathologists, oncologists, clinicians, pharmaceutical companies, and clinical laboratories. It also provides cytogenetics testing services to study normal and abnormal chromosomes and their relationship to diseases; fluorescence in-situ hybridization testing services that focus on detecting and locating the presence or absence of specific DNA sequences and genes on chromosomes; flow cytometry testing services to measure the characteristics of cell populations; and immunohistochemistry and digital imaging testing services to localize cellular proteins in tissue section, as well as to allow clients to visualize scanned slides, and perform quantitative analysis for various stains. In addition, the company also provides molecular testing services, which focus on the analysis of DNA and/or RNA, and the structure and function of genes at the molecular level; morphologic analysis, which is the process of analyzing cells under the microscope by a pathologist for the purpose of diagnosis; and testing services in support of its pharmaceutical clients' oncology programs covering discovery and commercialization. NeoGenomics, Inc. was founded in 2001 and is headquartered in Fort Myers, Florida.